𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia

✍ Scribed by Yesid Alvarado; Jorge Cortes; Srdan Verstovsek; Deborah Thomas; Stephan Faderl; Zeev Estrov; Hagop Kantarjian; Francis J. Giles

Publisher
Springer
Year
2003
Tongue
English
Weight
196 KB
Volume
51
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pegylated interferon alpha-2b plus ribav
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues
✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of

Treatment of chronic hepatitis E in live
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b
✍ Elizabeth B. Haagsma; Annelies Riezebos-Brilman; Arie P. van den Berg; Robert J. πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

Hepatitis E virus (HEV) infections are known to run a self-limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid-organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is curren